Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 372

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 372
---
|:-----------------------------------|:--|---:|:--|:--|:--|:-----|:--|---:|:--|:--|:--|:---------------------------------|:--|----:|:--|:--|:--|:-----|:--|---:|:--|:--|
| Operating cash flows from operating leases | ​ | ​ | ​                                  | $ | 50 | ​ | ​ | ​ | ​    | $ | 49 | ​ | ​ | ​ | ​                                | $ | 100 | ​ | ​ | ​ | ​    | $ | 98 | ​ | ​ |

The weighted-average discount rate and remaining lease term were as follows:

| ​                                     | ​ | ​ | For the Three MonthsEnded June 30, |   |       |   |   |   |      |   |       |   | ​ | ​ | For the Six MonthsEnded June 30, |   |       |   |   |   |      |   |       |   | ​ |
| ​                                     | ​ | ​ |                               2025 |   |       |   | ​ | ​ | 2024 |   |       |   | ​ | ​ |                             2025 |   |       |   | ​ | ​ | 2024 |   |       |   | ​ |
| Weighted-average discount rate        | ​ | ​ |                                  ​ | ​ | 9.50% | ​ | ​ | ​ |    ​ | ​ | 9.50% | ​ | ​ | ​ |                                ​ | ​ | 9.50% | ​ | ​ | ​ |    ​ | ​ | 9.50% | ​ | ​ |
| Weighted-average remaining lease term | ​ | ​ |                                  ​ | ​ |  2.08 | ​ | ​ | ​ |    ​ | ​ |  3.08 | ​ | ​ | ​ |                                ​ | ​ |  2.08 | ​ | ​ | ​ |    ​ | ​ |  3.08 | ​ | ​ |

As of June 30, 2025, the maturities of the Company’s operating lease liabilities were as follows (in thousands):

| Year Ended December 31,                             
 2025 (remaining six months)                         | ​ 
 ​ | ​ 
 ​ | Amount 
 ​      |   |  64 | ​ | ​ 
 ​ |